epirubicin has been researched along with Sarcoma 180 in 2 studies
*Sarcoma 180: An experimental sarcoma of mice. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcamone, F; Bargiotii, A; Casazza, AM; Cassinelli, G; Dasdia, T; Di Marco, A; Hanessian, S; Necco, A; Redaelli, S; Reggiani, P; Supino, R | 1 |
| Deng, Y; Jiao, J; Li, J; Wang, C; Yang, Q; Zhang, T | 1 |
2 other study(ies) available for epirubicin and Sarcoma 180
| Article | Year |
|---|---|
Stereocontrolled glycosidation of daunomycinone. Synthesis and biological evaluation of 6-hydroxy-L-arabino analogues of antitumor anthracyclines.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Arabinose; Cells, Cultured; Daunorubicin; Doxorubicin; Embryo, Mammalian; HeLa Cells; In Vitro Techniques; Mice; Moloney murine leukemia virus; Nucleosides; Sarcoma 180 | 1976 |
Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Compounding; Epirubicin; Glycoproteins; Liposomes; Male; Metformin; Mice, Inbred Strains; Microscopy, Electron, Transmission; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; Polyethylene Glycols; Sarcoma 180; Surface Properties | 2014 |